TNYA vs TVGN

Tenaya Therapeutics, Inc. vs Tevogen Bio Holdings Inc. — Valuation Comparison 2026

TNYA

Biological Products, (No Diagnostic Substances)
Tenaya Therapeutics, Inc.
Quality
4.1
out of 10
Value Trap
30
LOW
Price
$0.87
Last close
Models
8/13
Active
VS

TVGN

Biological Products, (No Diagnostic Substances)
Tevogen Bio Holdings Inc.
Quality
3.0
out of 10
Value Trap
24
SAFE
Price
$7.91
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType TNYA Fair ValueTNYA Upside TVGN Fair ValueTVGN Upside
Bayesian DCF Intrinsic $0.40 -54.5% $2.60 -67.2%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $0.79 -9.1% $0.41 -94.8%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for TNYA vs TVGN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TNYA vs TVGN — Which Stock Is More Undervalued?

TNYA scores higher with a 4.1/10 quality rating vs TVGN's 3.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Tenaya Therapeutics, Inc. (TNYA) and Tevogen Bio Holdings Inc. (TVGN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TNYA currently trades at $0.87 with a QOC of 4.1/10, while TVGN trades at $7.91 with a QOC of 3.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).